Kazuhiro Nako

908 total citations
27 papers, 731 citations indexed

About

Kazuhiro Nako is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Kazuhiro Nako has authored 27 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Nephrology. Recurrent topics in Kazuhiro Nako's work include Diabetes Management and Research (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Blood Pressure and Hypertension Studies (5 papers). Kazuhiro Nako is often cited by papers focused on Diabetes Management and Research (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Blood Pressure and Hypertension Studies (5 papers). Kazuhiro Nako collaborates with scholars based in Japan. Kazuhiro Nako's co-authors include Sadayoshi Ito, Susumu Ogawa, Takefumi Mori, Masashi Okamura, Miho Senda, Kazuhisa Takeuchi, Takuya Sakamoto, T. KATO, Tsuneo Ishizuka and Masato Matsushima and has published in prestigious journals such as Hypertension, Clinical Journal of the American Society of Nephrology and BMJ Open.

In The Last Decade

Kazuhiro Nako

27 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuhiro Nako Japan	13	339	229	124	112	106	27	731
Samy Hadjadj France	16	224 0.7×	177 0.8×	168 1.4×	96 0.9×	196 1.8×	32	808
Yoichi Ohno Japan	16	204 0.6×	207 0.9×	180 1.5×	87 0.8×	138 1.3×	66	791
H. J. G. Bilo Netherlands	18	401 1.2×	215 0.9×	92 0.7×	164 1.5×	136 1.3×	43	991
Kenzo Oba Japan	14	379 1.1×	152 0.7×	76 0.6×	172 1.5×	137 1.3×	56	761
Draženka Pongrac Barlovič Slovenia	13	355 1.0×	161 0.7×	299 2.4×	178 1.6×	181 1.7×	26	1.1k
Nakayasu Wake Japan	4	565 1.7×	103 0.4×	80 0.6×	100 0.9×	184 1.7×	5	822
Carlos Arauz-Pacheco United States	11	365 1.1×	246 1.1×	109 0.9×	116 1.0×	124 1.2×	15	722
Wiesława Łysiak−Szydłowska Poland	18	145 0.4×	142 0.6×	197 1.6×	80 0.7×	160 1.5×	46	786
Sameer Stas United States	11	336 1.0×	275 1.2×	61 0.5×	169 1.5×	156 1.5×	12	787
Margarita Torres‐Tamayo Mexico	14	233 0.7×	292 1.3×	44 0.4×	119 1.1×	107 1.0×	50	969

Countries citing papers authored by Kazuhiro Nako

Since Specialization

Citations

This map shows the geographic impact of Kazuhiro Nako's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Nako with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Nako more than expected).

Fields of papers citing papers by Kazuhiro Nako

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Nako. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Nako. The network helps show where Kazuhiro Nako may publish in the future.

Co-authorship network of co-authors of Kazuhiro Nako

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Nako. A scholar is included among the top collaborators of Kazuhiro Nako based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Nako. Kazuhiro Nako is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ogawa, Susumu, Yusuke Ohsaki, Kazuhiro Nako, et al.. (2021). Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial. Diabetology International. 13(1). 209–219. 13 indexed citations

Ogawa, Susumu, et al.. (2018). Decreased Glycaemia with Renal Failure in Diabetes Betides in Relation to the Change in Renal Glutamate Metabolism. 3(1). 2 indexed citations

Ogawa, Susumu, et al.. (2017). The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabetics. Clinical and Experimental Nephrology. 21(6). 1044–1052. 4 indexed citations

Ogawa, Susumu, et al.. (2016). The Reduction in Urinary Glutamate Excretion Is Responsible for Lowering Urinary pH in Pink Urine Syndrome. The Tohoku Journal of Experimental Medicine. 239(2). 103–110. 8 indexed citations

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, & Sadayoshi Ito. (2015). Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes. BMJ Open Diabetes Research & Care. 3(1). e000097–e000097. 8 indexed citations

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2014). Elucidation of the etiology and characteristics of pink urine in young healthy subjects. Clinical and Experimental Nephrology. 19(5). 822–829. 10 indexed citations

Senda, Miho, Susumu Ogawa, Kazuhiro Nako, et al.. (2014). The strong relation between post-hemodialysis blood methylglyoxal levels and post-hemodialysis blood glucose concentration rise. Clinical and Experimental Nephrology. 19(3). 527–533. 10 indexed citations

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2013). Compared with insulin glargine, insulin degludec narrows the day-to-day variability in the glucose-lowering effect rather than lowering blood glucose levels. Journal of Diabetes Mellitus. 3(4). 244–251. 7 indexed citations

Ogawa, Susumu, Masato Matsushima, Takefumi Mori, et al.. (2013). Identification of the Stages of Diabetic Nephropathy at Which Angiotensin II Receptor Blockers Most Effectively Suppress Albuminuria. American Journal of Hypertension. 26(9). 1064–1069. 7 indexed citations

10.

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2013). A Decline in Glomerular Filtration Rate Rather than Renal Arterial Stenotic Lesions, per se, Predicts Cardiovascular-Renal Events in Type 2 Diabetic Patients. Circulation Journal. 77(11). 2816–2822. 5 indexed citations

11.

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2012). Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitus. BMJ Open. 2(2). e000830–e000830. 40 indexed citations

12.

Senda, Miho, Susumu Ogawa, Kazuhiro Nako, et al.. (2012). The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. Endocrine Journal. 59(10). 889–894. 59 indexed citations

13.

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2011). Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes. The Tohoku Journal of Experimental Medicine. 223(2). 133–135. 94 indexed citations

14.

Ogawa, Susumu, Kazuhiro Nako, Masashi Okamura, et al.. (2011). Diagnosis and Treatment of Diabetic Patients Requiring Insulin Who Repeatedly Manifest Hyperglycemia and Hypoglycemia Due to Anti-Insulin Antibodies. Clinical Diabetes. 29(4). 148–150. 3 indexed citations

15.

Ishizuka, Tsuneo, Susumu Ogawa, Takefumi Mori, et al.. (2009). Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Research and Clinical Practice. 84(2). e21–e23. 41 indexed citations

16.

Ogawa, Susumu, Takefumi Mori, Kazuhiro Nako, & Sadayoshi Ito. (2008). Combination Therapy with Renin-Angiotensin System Inhibitors and the Calcium Channel Blocker Azelnidipine Decreases Plasma Inflammatory Markers and Urinary Oxidative Stress Markers in Patients with Diabetic Nephropathy. Hypertension Research. 31(6). 1147–1155. 43 indexed citations

17.

Ogawa, Susumu, Takefumi Mori, Kazuhiro Nako, Tsuneo Ishizuka, & Sadayoshi Ito. (2008). Reduced Albuminuria with Sarpogrelate Is Accompanied by a Decrease in Monocyte Chemoattractant Protein-1 Levels in Type 2 Diabetes. Clinical Journal of the American Society of Nephrology. 3(2). 362–368. 23 indexed citations

18.

Ogawa, Susumu, Kazuhisa Takeuchi, Takefumi Mori, et al.. (2007). Effects of Monotherapy of Temocapril or Candesartan with Dose Increments or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy. Hypertension Research. 30(4). 325–334. 39 indexed citations

19.

Ogawa, Susumu, Kazuhisa Takeuchi, Takefumi Mori, Kazuhiro Nako, & Sadayoshi Ito. (2006). SPIRONOLACTONE FURTHER REDUCES URINARY ALBUMIN EXCRETION AND PLASMA B‐TYPE NATRIURETIC PEPTIDE LEVLES IN HYPERTENSIVE TYPE II DIABETES TREATED WITH ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR. Clinical and Experimental Pharmacology and Physiology. 33(5-6). 477–479. 21 indexed citations

20.

Ogawa, Susumu, Takefumi Mori, Kazuhiro Nako, et al.. (2006). Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy. Hypertension. 47(4). 699–705. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact